Sort
141,003 grants matching “cytokine”
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure
$867,419David M. Underhill · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis
$867,404Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AG
Age-associated alterations in pro-inflammatory gene expression in humans
$867,403Ranjan Sen · National Institute On Aging · ZIA · FY2020 · AG
Depression in Older Asthmatics: Understanding Inflammatory and Behavioral Pathways
$867,332Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure
$867,246Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2019 · HL
MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development
$867,215Stella Kourembanas · Boston Children'S Hospital · R01 · FY2024 · HL
Associations of Gut Microbiome Predictors of Body Fat Amount and Distribution
$867,138Johanna W Lampe · University Of Hawaii At Manoa · P01 · FY2013 · CA
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy
$867,135Asrar B. Malik · Nano Biotherapeutics, Inc. · R42 · FY2018 · HL
Countermeasures for Bioterroism Targeting Cellular Host Factors
$867,102John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2011 · AI
Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery
$866,762Richard A Jonas · Children'S Research Institute · R33 · FY2020 · HL
Function and Differentiation
$866,753Marion Pepper · University Of Washington · R56 · FY2023 · AI
Innate and Adaptive Immunity to Microbial Flagellins in IBD
$866,415Charles O Elson · University Of Alabama At Birmingham · P01 · FY2011 · DK
Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
$866,370Wendy Cozen · University Of California-Irvine · R01 · FY2024 · CA
Innate and Adaptive Immunity to Microbial Flagellins in IBD
$866,074Charles O Elson · University Of Alabama At Birmingham · P01 · FY2014 · DK
Innate and Adaptive Immunity to Microbial Flagellins in IBD
$866,072Charles O Elson · University Of Alabama At Birmingham · P01 · FY2012 · DK
Studies of Human T Regulatory Cells
$866,060Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Immune Responses To Ocular Antigens
$865,900Igal Gery · National Eye Institute · ZIA · FY2016 · EY
TRAUMA PRIMES CELLS
$865,843University Of Colorado Denver · P50 · FY2001 · GM
Engineering human islet-like organoids for transplantation
$865,800Ronald M. Evans · Salk Institute For Biological Studies · R01 · FY2018 · DK
Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment
$865,755Laura J Van't Veer · University Of California, San Francisco · P01 · FY2023 · CA
India International Center for Excellence in Research
$865,570Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Effect of weight loss on intermuscular adipose tissue (IMAT) signaling
$865,496Bryan C Bergman · University Of Colorado Denver · R01 · FY2025 · DK
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$865,457Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2015 · AI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$865,457Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2016 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$865,406Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA